Sweet Cheeks
Natural health product licensed in Canada
- Licence holder
- Tarry Medical Products Inc. dba Dandlelion Medical
- NPN or DIN-HM
- 80111503
- Status
- Active licence
- Licence date
- 19 July 2021
- Revision date
- 23 August 2022
- Form
- Gel
- Route of administration
- Buccale
- Application type
- Générale (non traditionelle)
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Citrate de sodium, Glycérine, Sorbate de potassium, Acide citrique anhydre, Eau purifiée, Carboxyméthylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | maximum: 12 months | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Reducing procedural pain, soothing and calming. Use to take control of low blood sugar.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80111503
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.